𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

✍ Scribed by Debby Van Dam; Katrien Coen; Peter Paul De Deyn

Publisher
Springer
Year
2007
Tongue
English
Weight
159 KB
Volume
197
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-mnestic cognitive function in the sc
Non-mnestic cognitive function in the scopolamine model of Alzheimer's Disease
✍ Marc C. Obonsawin; Anne Robertson; John R. Crawford; Chris Perera; Shona Walker; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

The contribution of cholinergic dysfunction to the non-mnestic cognitive impairments associated with senile dementia of the Alzheimer type (SDAT) was investigated. Scopolamine (0 . 5 mg) was administered intravenously to 12 healthy individuals, and their performance on selected subtests of the Wechs

A comparison of donepezil and galantamin
A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis
✍ Robin D. J. Harry; Konstantine K. Zakzanis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

This review was conducted in order to determine the efficacy of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease, and also to determine whether galantamine was a superior pharmacological intervention. Meta-analytic methods were used to analyse the data from eig